Document is current

Any future updates will be listed below

Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)

Crossref DOI link: https://doi.org/10.1007/s41669-017-0048-x

Published Online: 2017-08-22

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark